引用本文
  •    [点击复制]
  •    [点击复制]
【打印本页】 【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 1492次   下载 865 本文二维码信息
码上扫一扫!
流产布鲁氏菌ATP/GTP结合蛋白基因缺失株保护力及安全性研究
王真1, 欧齐星1, 王双山2, 吕艳丽1, 吴清民1
0
(1.中国农业大学 动物医学院, 北京 100193;2.安阳工学院 生物学院, 河南 安阳 455000)
摘要:
为筛选具有诊断标记的布鲁氏菌病疫苗菌株,本研究利用同源重组和负筛选技术,构建了流产布鲁氏菌株2 308的ATP/GTP结合蛋白基因缺失株BDA14,并通过菌落染色和凝集特性,培养传代,小鼠接种试验及怀孕羊攻毒试验对其生物学特性、安全性和免疫效果进行了研究。结果表明:1)缺失菌株BDA14为粗糙型菌株,体外培养传代表型不发生改变;2)缺失菌株BDA14在小鼠体内的毒力与亲本菌株2308相比显著降低,且不产生针对OPS(O-antigen)的抗体;3)缺失菌株BDA14可提供与疫苗株RB51相当的攻毒保护力;4)缺失菌株BDA14对怀孕靶动物的安全性显著提高,接种怀孕羊不引起流产。说明ATP/GTP结合蛋白基因缺失株BDA14作为安全、有效且能鉴别诊断的疫苗菌株有明显优势。
关键词:  流产布鲁氏菌  ATP/GTP结合蛋白基因  表型  毒力  免疫效力
DOI:10.11841/j.issn.1007-4333.2013.03.020
投稿时间:2012-10-24
基金项目:国家"973"计划项目(2010CB530202)
Studies on protective efficacy and safety of Brucella abortusATP/GTP binding protein gene deleted mutant
WANG Zhen1, OU Qi-xing1, WANG Shuang-shan2, LÜ Yan-li1, WU Qing-min1
(1.College of Veterinary Medicine, China Agricultural University, Beijing 100193, China;2.College of Biological Science, Anyang Institute of Technology, Anyang 455000, China)
Abstract:
Using homologous recombination and negative screening techniques,we constructed ATP/GTP binding protein gene deletion mutant which was named as BDA14 of B. abortus 2308 and studied the biological characteristics,safety,and induced protective immunity by staining and agglutination properties of colonies,passage stability test,mice inoculation assay,and pregnant sheep and goat challenge study.Study results showed that:1) The mutant BDA14 is rough-strain,and the phenotype of BDA14 did not changed after 20 consecutive passages in media;2) the mutant BDA14 was attenuated in virulence compared to its parent strain in mice model,and it did not induce antibodies against O-antigen;3) The mutant BDA14 can confer similar protection against challenges to vaccine strain RB51;4) The safety of BDA14 was significantly improved without induce abortion in pregnant sheep and goat.Therefore,The ATP/GTP binding protein gene deletion mutant BDA14 possess superiority acts as a safe,effective and differential diagnosis vaccine candidate,which is necessary to further study.
Key words:  Brucella abortus  ATP/GTP binding protein gene  penotype  virulence  immune efficacy